BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 19889264)

  • 1. Model for end-stage liver disease (MELD) score as a useful prognostic marker in cirrhotic patients with infection.
    Khan R; Abid S; Jafri W; Awan S; Hamid S; Shah H; Pervez S
    J Coll Physicians Surg Pak; 2009 Nov; 19(11):694-8. PubMed ID: 19889264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can inclusion of serum creatinine values improve the Child-Turcotte-Pugh score and challenge the prognostic yield of the model for end-stage liver disease score in the short-term prognostic assessment of cirrhotic patients?
    Giannini E; Botta F; Fumagalli A; Malfatti F; Testa E; Chiarbonello B; Polegato S; Bellotti M; Milazzo S; Borgonovo G; Testa R
    Liver Int; 2004 Oct; 24(5):465-70. PubMed ID: 15482344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of model for end-stage liver disease score to serum sodium ratio index as a prognostic predictor in patients with cirrhosis.
    Lv XH; Liu HB; Wang Y; Wang BY; Song M; Sun MJ
    J Gastroenterol Hepatol; 2009 Sep; 24(9):1547-53. PubMed ID: 19686416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Model for End-Stage Liver Disease score: an independent prognostic factor of mortality in injured cirrhotic patients.
    Inaba K; Barmparas G; Resnick S; Browder T; Chan LS; Lam L; Talving P; Demetriades D
    Arch Surg; 2011 Sep; 146(9):1074-8. PubMed ID: 21576598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proposal of a modified Child-Turcotte-Pugh scoring system and comparison with the model for end-stage liver disease for outcome prediction in patients with cirrhosis.
    Huo TI; Lin HC; Wu JC; Lee FY; Hou MC; Lee PC; Chang FY; Lee SD
    Liver Transpl; 2006 Jan; 12(1):65-71. PubMed ID: 16382473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the increase in model for end-stage liver disease (DeltaMELD) score over time as a prognostic predictor in patients with advanced cirrhosis: risk factor analysis and comparison with initial MELD and Child-Turcotte-Pugh score.
    Huo TI; Wu JC; Lin HC; Lee FY; Hou MC; Lee PC; Chang FY; Lee SD
    J Hepatol; 2005 Jun; 42(6):826-32. PubMed ID: 15885353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Applicability of MELD as a short-term prognostic indicator in patients with chronic liver disease: an Indian experience.
    Mishra P; Desai N; Alexander J; Singh DP; Sawant P
    J Gastroenterol Hepatol; 2007 Aug; 22(8):1232-5. PubMed ID: 17688663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MELD era: is this time to replace the original Child-Pugh score in patients with decompensated cirrhosis of liver.
    Shaikh S; Ghani H; Memon S; Baloch GH; Jaffery M; Shaikh K
    J Coll Physicians Surg Pak; 2010 Jul; 20(7):432-5. PubMed ID: 20642940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Usefulness of DeltaMELD/month for prediction of the mortality in the first episode of variceal bleeding patients with liver cirrhosis: comparison with CTP, MELD score and DeltaCTP/month].
    Bae WK; Lee JS; Kim NH; Kim KA; Moon YS; Oh MK
    Korean J Hepatol; 2007 Mar; 13(1):51-60. PubMed ID: 17380075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical features and predictors of outcome in acute hepatitis A and hepatitis E virus hepatitis on cirrhosis.
    Radha Krishna Y; Saraswat VA; Das K; Himanshu G; Yachha SK; Aggarwal R; Choudhuri G
    Liver Int; 2009 Mar; 29(3):392-8. PubMed ID: 19267864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of pretransplant MELD score on posttransplant outcome in orthotopic liver transplantation for patients with acute-on-chronic hepatitis B liver failure.
    Wang ZX; Yan LN; Wang WT; Xu MQ; Yang JY
    Transplant Proc; 2007 Jun; 39(5):1501-4. PubMed ID: 17580172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-hospital mortality in spontaneous bacterial peritonitis: a new predictive model.
    Nobre SR; Cabral JE; Gomes JJ; Leitão MC
    Eur J Gastroenterol Hepatol; 2008 Dec; 20(12):1176-81. PubMed ID: 18941414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of model for end-stage liver disease (MELD) score on prognosis after hepatectomy for hepatocellular carcinoma on cirrhosis.
    Cucchetti A; Ercolani G; Vivarelli M; Cescon M; Ravaioli M; La Barba G; Zanello M; Grazi GL; Pinna AD
    Liver Transpl; 2006 Jun; 12(6):966-71. PubMed ID: 16598792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The anaylsis of mortality rate according to CTP score and MELD score in patients with liver cirrhosis].
    Jeong EM; Hwang SG; Park HH; Park JH; Kim HT; Oh SW; Kho KH; Hong SP; Park PW; Rim GS; Kim SH
    Taehan Kan Hakhoe Chi; 2003 Jun; 9(2):98-106. PubMed ID: 12824749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated soluble tumor necrosis factor receptor 75 concentrations identify patients with liver cirrhosis at risk of death.
    Grünhage F; Rezori B; Neef M; Lammert F; Sauerbruch T; Spengler U; Reichel C
    Clin Gastroenterol Hepatol; 2008 Nov; 6(11):1255-62. PubMed ID: 18995216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors, sequential organ failure assessment and model for end-stage liver disease scores for predicting short term mortality in cirrhotic patients admitted to intensive care unit.
    Cholongitas E; Senzolo M; Patch D; Kwong K; Nikolopoulou V; Leandro G; Shaw S; Burroughs AK
    Aliment Pharmacol Ther; 2006 Apr; 23(7):883-93. PubMed ID: 16573791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Child-Turcotte-Pugh versus MELD score as a predictor of outcome after elective and emergent surgery in cirrhotic patients.
    Farnsworth N; Fagan SP; Berger DH; Awad SS
    Am J Surg; 2004 Nov; 188(5):580-3. PubMed ID: 15546574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New scoring systems for severity outcome of liver cirrhosis and hepatocellular carcinoma: current issues concerning the Child-Turcotte-Pugh score and the Model of End-Stage Liver Disease (MELD) score].
    Lee DH; Son JH; Kim TW
    Taehan Kan Hakhoe Chi; 2003 Sep; 9(3):167-79. PubMed ID: 14515034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The 1-year and 3-month prognostic utility of the AST/ALT ratio and model for end-stage liver disease score in patients with viral liver cirrhosis.
    Giannini E; Botta F; Testa E; Romagnoli P; Polegato S; Malfatti F; Fumagalli A; Chiarbonello B; Risso D; Testa R
    Am J Gastroenterol; 2002 Nov; 97(11):2855-60. PubMed ID: 12425560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of serum creatinine and prognostic scoring systems in assessing hospital mortality in critically ill cirrhotic patients with upper gastrointestinal bleeding.
    Chen YC; Tsai MH; Hsu CW; Ho YP; Lien JM; Chang MY; Fang JT; Huang CC; Chen PC
    J Nephrol; 2003; 16(4):558-65. PubMed ID: 14696759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.